Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

UiPath helps companies automate tasks traditionally performed by human employees with software robots. The slower-growth company might be the safer bet in this frothy market. Figma (NYSE: FIG) and ...

Learn more about whether Adeia Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare ...

Info-Tech Research Group has unveiled 2025's Most Loved Software Solutions, recognizing the top ten software solutions that achieved the highest levels of user satisfaction based on verified end-user ...

Robotics is poised for steady growth in 2026. Consider PATH, NVDA, CDNS and ISRG for potential market dominance across sectors.

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

Discover the leading workflow automation tools for enterprises in 2026, empowering businesses to enhance efficiency, streamline operations, and embrace digital transformation with AI-enabled solutions ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the OSWorld-Verified benchmark, an ...

There’s a familiar story in enterprise AI circles: agentic AI is “the next big thing,” something we should discuss, plan for, or pilot before it becomes real. And that future is already here, quietly ...

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.